OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Combination therapy for hypertension: focus on high-dose olmesartan medoxomil (40 mg) plus hydrochlorothiazide
Lars Christian Rump, Lorenz Sellin
Expert Opinion on Pharmacotherapy (2010) Vol. 11, Iss. 13, pp. 2231-2242
Closed Access | Times Cited: 8
Lars Christian Rump, Lorenz Sellin
Expert Opinion on Pharmacotherapy (2010) Vol. 11, Iss. 13, pp. 2231-2242
Closed Access | Times Cited: 8
Showing 8 citing articles:
Paraoxonase 1 as a Major Bioactivating Hydrolase for Olmesartan Medoxomil in Human Blood Circulation: Molecular Identification and Contribution to Plasma Metabolism
Tomoko Ishizuka, Izumi Fujimori, Atsuko Nishida, et al.
Drug Metabolism and Disposition (2011) Vol. 40, Iss. 2, pp. 374-380
Closed Access | Times Cited: 30
Tomoko Ishizuka, Izumi Fujimori, Atsuko Nishida, et al.
Drug Metabolism and Disposition (2011) Vol. 40, Iss. 2, pp. 374-380
Closed Access | Times Cited: 30
Interindividual Variability of Carboxymethylenebutenolidase Homolog, a Novel Olmesartan Medoxomil Hydrolase, in the Human Liver and Intestine
Tomoko Ishizuka, Veronika Rozehnal, Thomas M. Fischer, et al.
Drug Metabolism and Disposition (2013) Vol. 41, Iss. 5, pp. 1156-1162
Closed Access | Times Cited: 13
Tomoko Ishizuka, Veronika Rozehnal, Thomas M. Fischer, et al.
Drug Metabolism and Disposition (2013) Vol. 41, Iss. 5, pp. 1156-1162
Closed Access | Times Cited: 13
Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice
Peter Bramlage, Claudia Zemmrich, Ketelhut, et al.
Vascular Health and Risk Management (2013), pp. 475-475
Open Access | Times Cited: 7
Peter Bramlage, Claudia Zemmrich, Ketelhut, et al.
Vascular Health and Risk Management (2013), pp. 475-475
Open Access | Times Cited: 7
Angiotensin II receptor blocker combinations: From guidelines to clinical practice
Krzysztof Narkiewicz
Blood Pressure (2011) Vol. 21, Iss. 2, pp. 73-81
Open Access | Times Cited: 5
Krzysztof Narkiewicz
Blood Pressure (2011) Vol. 21, Iss. 2, pp. 73-81
Open Access | Times Cited: 5
Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control
Massimo Volpe, Caterina Santolamazza, Vittoria Mastromarino, et al.
High Blood Pressure & Cardiovascular Prevention (2017) Vol. 24, Iss. 3, pp. 243-253
Closed Access | Times Cited: 5
Massimo Volpe, Caterina Santolamazza, Vittoria Mastromarino, et al.
High Blood Pressure & Cardiovascular Prevention (2017) Vol. 24, Iss. 3, pp. 243-253
Closed Access | Times Cited: 5
Combination therapy with losartan/hydrochlorothiazide for blood pressure reduction and goal attainment in a real-world clinical setting in Japan
Hiromichi Suzuki, Yukio Shimada, Kenji Fujiwara
Therapeutic Advances in Cardiovascular Disease (2012) Vol. 6, Iss. 6, pp. 237-244
Closed Access | Times Cited: 3
Hiromichi Suzuki, Yukio Shimada, Kenji Fujiwara
Therapeutic Advances in Cardiovascular Disease (2012) Vol. 6, Iss. 6, pp. 237-244
Closed Access | Times Cited: 3
Identification of non-P450 enzymes involved in the metabolism of new drugs: Their significance in drug interaction evaluation and prodrug disposition
Yumi Nishiya, Eiko Suzuki, Tomoko Ishizuka, et al.
Drug Metabolism and Pharmacokinetics (2019) Vol. 35, Iss. 1, pp. 45-55
Closed Access | Times Cited: 3
Yumi Nishiya, Eiko Suzuki, Tomoko Ishizuka, et al.
Drug Metabolism and Pharmacokinetics (2019) Vol. 35, Iss. 1, pp. 45-55
Closed Access | Times Cited: 3
Current World Literature
Current Opinion in Nephrology & Hypertension (2011) Vol. 20, Iss. 5, pp. 561-571
Closed Access
Current Opinion in Nephrology & Hypertension (2011) Vol. 20, Iss. 5, pp. 561-571
Closed Access
